- Home
- MMA vs LYRA Comparison
MMA vs LYRA Comparison
Compare MMA & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- LYRA
- Stock Information
- Founded
- MMA 2013
- LYRA 2005
- Country
- MMA Australia
- LYRA United States
- Employees
- MMA N/A
- LYRA N/A
- Industry
- MMA
- LYRA Medical/Dental Instruments
- Sector
- MMA
- LYRA Health Care
- Exchange
- MMA Nasdaq
- LYRA Nasdaq
- Market Cap
- MMA 11.1M
- LYRA 11.3M
- IPO Year
- MMA 2024
- LYRA 2020
- Fundamental
- Price
- MMA $1.81
- LYRA $6.27
- Analyst Decision
- MMA
- LYRA Hold
- Analyst Count
- MMA 0
- LYRA 1
- Target Price
- MMA N/A
- LYRA $16.00
- AVG Volume (30 Days)
- MMA 11.0M
- LYRA 15.1K
- Earning Date
- MMA 01-01-0001
- LYRA 11-11-2025
- Dividend Yield
- MMA N/A
- LYRA N/A
- EPS Growth
- MMA N/A
- LYRA N/A
- EPS
- MMA N/A
- LYRA N/A
- Revenue
- MMA $407,412.00
- LYRA $770,000.00
- Revenue This Year
- MMA N/A
- LYRA N/A
- Revenue Next Year
- MMA N/A
- LYRA $123.46
- P/E Ratio
- MMA N/A
- LYRA N/A
- Revenue Growth
- MMA N/A
- LYRA N/A
- 52 Week Low
- MMA $0.60
- LYRA $3.81
- 52 Week High
- MMA $4.11
- LYRA $37.50
- Technical
- Relative Strength Index (RSI)
- MMA 78.07
- LYRA 35.00
- Support Level
- MMA $0.80
- LYRA $6.15
- Resistance Level
- MMA $3.07
- LYRA $6.72
- Average True Range (ATR)
- MMA 0.27
- LYRA 0.38
- MACD
- MMA 0.11
- LYRA -0.04
- Stochastic Oscillator
- MMA 44.25
- LYRA 15.99
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.